GlaxoSmithKline Pharmaceuticals Ltd.

BSE: 500660 | NSE: GLAXO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE159A01016 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

GlaxoSmithKlin GlaxoSmithKline Pharmaceuticals Ltd. | BSE 2273.60 -56.00 (-2.40%) | NSE 2272.60 -57.00 (-2.45%) | Trade | Add

BSE Live

Jan 20, 16:01

2273.60 -56.00 (-2.40%)

Volume

AVERAGE VOLUME

5-Day

2,304

10-Day

2,703

30-Day

6,275

4,775

Prev. Close

2329.60
Open Price

2329.60

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 20, 15:53

2272.60 -57.00 (-2.45%)

Volume

AVERAGE VOLUME

5-Day

48,290

10-Day

61,240

30-Day

84,698

100,472

Prev. Close

2329.60
Open Price

2329.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2272.60 (776)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of GlaxoSmithKline Pharmaceuticals (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Per Share Ratios
Basic EPS (Rs.)	54.01	40.83	35.90	99.05	31.32
Diluted EPS (Rs.)	54.24	34.51	35.88	99.79	21.11
Cash EPS (Rs.)	58.19	38.63	39.76	103.82	25.75
Book Value [ExclRevalReserve]/Share (Rs.)	115.06	105.31	103.48	158.06	88.37
Book Value [InclRevalReserve]/Share (Rs.)	115.06	105.31	103.48	158.06	88.37
Dividend / Share(Rs.)	54.00	32.00	32.00	90.00	30.00
Revenue from Operations/Share (Rs.)	219.80	201.13	189.86	189.93	172.40
PBDIT/Share (Rs.)	77.44	60.45	53.18	49.12	41.79
PBIT/Share (Rs.)	73.50	56.34	49.30	45.09	37.15
PBT/Share (Rs.)	73.69	47.76	49.14	45.66	26.75
Net Profit/Share (Rs.)	54.25	34.51	35.88	99.79	21.11
Profitability Ratios
PBDIT Margin (%)	35.23	30.05	28.01	25.85	24.24
PBIT Margin (%)	33.43	28.01	25.96	23.74	21.54
PBT Margin (%)	33.52	23.74	25.88	24.03	15.51
Net Profit Margin (%)	24.68	17.16	18.89	52.54	12.24
Return on Networth / Equity (%)	47.14	32.77	34.66	63.13	23.88
Return on Capital Employed (%)	56.59	46.85	41.53	25.90	35.40
Return on Assets (%)	22.41	16.48	18.26	36.57	11.54
Total Debt/Equity (X)	0.00	0.00	0.00	0.00	0.00
Asset Turnover Ratio (%)	0.97	0.99	0.81	0.83	0.94
Liquidity Ratios
Current Ratio (X)	1.78	1.83	1.87	2.19	1.65
Quick Ratio (X)	1.54	1.49	1.54	1.89	1.25
Inventory Turnover Ratio (X)	7.62	1.06	0.83	1.07	0.90
Dividend Payout Ratio (NP) (%)	81.10	92.71	250.86	30.06	189.50
Dividend Payout Ratio (CP) (%)	75.60	82.84	226.37	28.89	155.35
Earnings Retention Ratio (%)	18.90	7.29	-150.86	69.94	-89.50
Cash Earnings Retention Ratio (%)	24.40	17.16	-126.37	71.11	-55.35
Valuation Ratios
Enterprise Value (Cr.)	47,342.30	31,856.08	21,281.16	25,692.26	23,243.59
EV/Net Operating Revenue (X)	12.71	9.35	6.62	7.99	7.96
EV/EBITDA (X)	36.09	31.11	23.62	30.88	32.83
MarketCap/Net Operating Revenue (X)	13.09	9.66	6.97	8.76	8.36
Retention Ratios (%)	18.89	7.28	-150.86	69.93	-89.50
Price/BV (X)	25.01	18.45	12.80	10.52	16.30
Price/Net Operating Revenue	13.09	9.66	6.97	8.76	8.36
Earnings Yield	0.02	0.02	0.03	0.06	0.01